SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets tough lung cancer
Disease control OngoingThis early-phase study tests a new drug called RYZ101 added to standard chemotherapy and immunotherapy for people with a specific type of advanced small cell lung cancer that has spread. The main goals are to find the best dose and check for side effects. About 21 adults who have…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New drug combo shows promise for tough lung cancer
Disease control OngoingThis study tests a new immunotherapy drug (HLX10) combined with standard chemotherapy in 26 Japanese patients with extensive-stage small cell lung cancer who have not had prior treatment. The goal is to see if the combination shrinks tumors and improves survival. Researchers will…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New combo therapy shows promise for tough lung cancer
Disease control OngoingThis study tests a new treatment for people with extensive stage small cell lung cancer who have not had prior therapy. It combines an experimental drug (AK104) with standard chemotherapy and low-dose radiation. The goal is to see if this combination is safe and helps control the…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE1, PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC